SNG001

Interferon beta-1a (inhaled formulation) · Synairgen Research Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for SNG001, covering 2012-02-13 to 2025-12-31. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection [Phase 2]